DrugMap: A quantitative pan-cancer analysis of cysteine ligandabilityMariko Takahashi, Liron Bar‐Peled, Sarah Reeves et al.|Cell|2024Cited by 94
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyXue Bai, Keith T. Flaherty, Eleonora Bongiovanni et al.|EClinicalMedicine|2023Cited by 26
DrugMap: A quantitative pan-cancer analysis of cysteine ligandabilityMariko Takahashi, Sarah Reeves, Harrison B. Chong et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 8